Additional file 1 of Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

Autor: Yokoyama, Masahiro, Kusano, Yoshiharu, Inoue, Norihito, Nishimura, Noriko, Mishima, Yuko, Nukada, Tomoyuki, Hatake, Kiyohiko, Terui, Yasuhito

Additional file 1 : Supplementary Table 1. Analysis settings and analysis usage variables. BMI body mass index, G-CSF granulocyte colony-stimulating factor, PS performance status. Supplementary Table 2 Univariate logistic regression analyses with and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4269c9d9d704b877cb58a604a28f00

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Safety and feasibility of outpatient management in relapsed/refractory lymphoma treated with pegfilgrastim after multi-agent salvage therapy: a single-center, open-label, non-randomized, prospective interventional study].

Autor: Iwasaki H; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center., Yamasaki S; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center., Kadowaki M; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center., Minami M; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center., Nukada T; Medical Affairs, Kyowa Kirin Co. Ltd., Takase K; Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center.

Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2023; Vol. 64 (7), pp. 596-607.